SUMMARY Thirteen patients have completed a randomised double blind cross over study to compare the effects of chronic ventricular and atrial synchronous pacing on exercise capacity and symptoms. Maximal symptom limited exercise was significantly increased after one month of atrial synchronous pacing compared with ventricular pacing. Symptomatic assessment (by diary card and monthly symptom scores) of "shortness of breath", "palpitation", and "general well-being" was significantly improved during the physiological pacing mode. Atrial synchronous pacing has been shown to be superior to ventricular pacing.
able which can restore the normal activation sequence of atrial contraction followed by ventricular systole and which, furthermore, can follow physiological increases in heart rate during exercise. The indications and applications of these pacemakers have recently been reviewed. 4 There remains controversy as to whether these more complex and, at present, more expensive pacemakers confer any real advantages to the patient. Pacemakers are now available which are programmable to either ventricular inhibited (VVI) pacing or a physiological mode (atrial sychronous ventricular inhibited, VDD or universal, DDD).5 It has been possible therefore using these pacemakers to compare these two modes of pacing in terms of both exercise performance and patient symptoms in a double blind trial.
Patients and methods PATIENT SELECTION Patients in whom a mode programmable VDD pacemaker had been implanted for at least three months were considered suitable candidates for the Accepted for publication 15 February 1983 trial. At the time of the study the exclusion criteria for implantation of a VDD pacemaker were: severe physical disability (for example arthritis or stroke), the coincidence of another disease with a short prognosis, chronic atrial fibrillation, the presence of dominant sinus rhythm with rare episodes of bradycardia, carotid sinus syndrome, retrograde atrioventricular conduction, isolated sick sinus syndrome, and very thin patients. In the four years before the trial 350 patients had been paced, of whom 42 had received VDD or VAT (ventricular paced atrial sensed) implants. Of these, only 16 were mode programmable (VDDM). One patient refused and two patients had intermittent 2:1 block at the time of the study, leaving 13 5  1  5  6  2200  3700  145  145  2  5  2  4  7  4300  4100  120  130  1  3  2  4  8  700  1300  145  140  3  3  3  3  9  1700  2350  125  125  3  3  1  4  10  2250  1900  82  85  3  3  2  3  11  2150  2800  140  145  2  4  2  3  12  2800  3100  145  130  2  3  2  4  13  3100  4400  110  150  1  3  1 4 Symptom scores for "general well-being".
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The patient's subjective sensation of well-being was much improved during physiological pacing (symptom scores 3.54+O008 VDD, 172+0-06 WI, p<001) (Fig. 4. This prospective controlled study has shown that physiological pacing increases the maximal effort tolerance of patients when compared with VVI pacing and that this improvement persists over a period of one month. This is in contrast to WI pacing where a diminution in haemodynamic performance has been seen chronically.'2 Three of the four patients with no benefit were found to have conducted intermittently during the stress test in the WI mode. If these patients are excluded from analysis of exercise data then the p value changes from <0.01 to <0.001.
Many patients with pacemakers, however, do not normally exercise to their maximum capacity and it is important therefore that subjective symptoms are improved by physiological systems. Ventricular pacing is an extremely effective treatment for preventing syncope caused by bradycardia and patients in the pacemaker clinic generally have few complaints after VVI pacing. Recent work, however, has shown that minor symptoms of dizziness and palpitation are common in WI paced patients because of atrioventricular dissociation or retrograde atrioventricular conduction, often termed the pacemaker syndrome. An extreme form of this is when syncope occurs usually at the onset of ventricular pacing.'3 Some groups of patients are exceptionally susceptible to this phenomenon, particularly patients with the hypersensitive carotid sinus syndrome."4 Similarly, patients with predominantly normal sinus rhythm may be acutely aware of the onset of ventricular pacing. This was one rationale behind the negative rate hysteresis pacemaker. 15 It is of importance therefore that subjective symptoms of dizziness and palpitation were less during the physiological mode, as was the improvement in the patient's overall feelings of well-being and improved effort tolerance. This occurred despite the fact that all of the patients had predominantly paced rhythm in the VVI mode and had been shown at electrophysiological study and subsequently not to exhibit retrograde atrioventricular conduction. There was considerable individual variation in symptoms, with patients often expressing a preference for the physiological mode with respect to a particular symptom without recording any specific instances of that symptom in the daily diary.
This study was designed as a within patient double blind trial. Unfortunately it was impossible to maintain blindness to the observer during the stress test and this may have biased the results. The intelligent patient could of course determine which mode he was in by feeling his own pulse and it is impossible to know how much this influenced the results. It is interesting to note that several patients were acutely aware of the change from WI to VDD mode. These problems could only be overcome by a large parallel group study.
This study has been carried out on a small selected group of patients and has shown clear symptomatic benefits of atrial synchronous pacing compared with ventricular inhibited pacing. Dual chambered pacing systems are, however, more complex and expensive and are not applicable to all patients. It does not seem justified to implant these systems in severely disabled patients or those with another terminal condition unless the patient has a clear symptomatic complication of WI pacing, for example pacemaker syndrome. These patients may, however, be managed more simply by rate hysteresis VVI pacingl6 or DVI pacing rather than VDD or DDD units. Permanent atrial fibrillation is a clear contraindication to any conventional atrial system; intermittent atrial fibrillation, however, may allow a DDD system to be implanted if the arrhythmia is suppressed with drugs such as amiodarone but it has not yet been our practice to do this. Retrograde atrioventricular conduction is a relative contraindication because of the possibility of pacemaker induced artificial circus movement tachycardias. This problem has recently been reviewed. '7 18 Retrograde conduction may be expected in about 13% of patients with complete heart block, 46% with intermittent (Mobitz II) block, and 89% of other patients with symptomatic bradycardia. 19 Though artificial circus movement tachycardias may be to some extent controlled by advances in technology (for example programmable atrial refractory period) in the newer multiprogrammable DDD Randomised controlled trial ofphysiological and ventricular pacing pacemakers and in some instances by drugs,20 retrograde atrioventricular conduction must be carefully assessed before implantation of a dual chamber atrial sensing system is contemplated. The physical size of these units is still a problem in some patients. At this centre only 30 to 400/o of patients presenting for pacing are found to be suitable for physiological pacing.
In conclusion this study has shown that physiological pacing offers improved effort tolerance and symptomatic improvement when compared with ventricular pacing. The increase in implant complexity and cost is clearly justified in selected patients, and atrial synchronous ventricular inhibited pacemakers should be at least considered in all patients with symptomatic bradycardia caused by atrioventricular block. The Autumn Meeting will be held at Wembley on 21 and 22 November 1983, and the closing date for abstracts was 26 July 1983.
The Annual General Meeting for 1984 will take place in Leicester on 11 and 12 April 1984, and the closing date for receipt of abstracts will be 3 January
1984.
The Autumn Meeting in 1984 will be held on 3 and 4 December 1984, and the closing date for receipt of abstracts will be 15 August 1984.
We regret the following errors in the paper in the August issue by Dr E J Perrins and others on randomised controlled trial of physiological and ventricular pacing (p 112). In the footnote to Table 1 CHB should read complete heart block and COCM should read congestive cardiomyopathy.
